Clinical Trial Update: Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer [Phase 2, Phase 3]

View source ↗

Summary

An open-label clinical trial assesses whether open-label placebo can reduce cancer-related fatigue in patients with advanced or metastatic solid tumors. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING